Stay updated on Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded the term 'Small cell lung carcinoma' to the page content and introduced a Resources section with a link to the Genetic and Rare Diseases Information Center.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe page revision has been updated to v3.5.0; the prior revision v3.4.3 has been superseded.SummaryDifference0.0%

- Check35 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the page history.SummaryDifference0.0%

- Check64 days agoChange DetectedA new Revision: v3.4.2 tag appears on the page, indicating a version update; there is no visible change to study details or instructions.SummaryDifference0.3%

- Check71 days agoChange DetectedAdded a site-wide notice about government funding status and NIH Clinical Center operations, and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.3%

- Check78 days agoChange DetectedAdded a new 'Show glossary' option. Updated metadata labels (e.g., 'Last Update Submitted that Met QC Criteria', capitalization of 'No FEAR Act Data') and introduced a 'Revision: v3.4.0' tag.SummaryDifference0.1%

Stay in the know with updates to Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab in Limited-Stage Small Cell Lung Cancer Clinical Trial page.